Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
about
Kinase inhibitor-responsive genotypes in EGFR mutated lung adenocarcinomas: moving past common point mutations or indels into uncommon kinase domain duplications and rearrangements.Novel EGFR Inhibitors in Non-small Cell Lung Cancer: Current Status of Afatinib.Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies.Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.Genomic alterations of ERBB receptors in cancer: clinical implications.Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.
P2860
Q37060709-EB202CD9-D402-4888-A929-79F90045D164Q38990576-46F0DD4D-5195-4993-BE66-4A13C74DD2EAQ39034581-C1844DA2-E460-42FD-B429-D68F85C17AC3Q44249512-10E87DAE-9164-4750-B469-0E5CA801B650Q46424042-3207934F-EC2E-477E-A2FF-B2E6533E91A1Q49678076-9D287166-989C-45D6-B1D0-BB58B2179F05Q52568478-C1B26AB3-E66C-40E6-A777-134486C2ECE5
P2860
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
@en
type
label
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
@en
prefLabel
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas.
@en
P2093
P2860
P50
P1476
Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas
@en
P2093
Jason P Moran
Jessica A Zerillo
Mark S Huberman
Susumu S Kobayashi
P2860
P304
P356
10.1016/J.JTHO.2016.02.016
P577
2016-03-08T00:00:00Z